High resolution allelotype of nonfunctional pancreatic endocrine tumors: Identification of two molecular subgroups with clinical implications

Cancer Research

Volumn 61, Issue 1, 2001, Pages 285-292

  Rigaud, Gildas ^a   Missiaglia, Edoardo ^a   Moore, Patrick S ^a   Zamboni, Giuseppe ^a   Falconi, Massimo ^b   Talamini, Giorgio ^c   Pesci, Anna ^a   Baron, Antonella ^a   Lissandrini, Daniele ^a   Rindi, Guido ^d   Grigolato, Piergiovanni ^d   Pederzoli, Paolo ^b   Scarpa, Aldo ^a  

^a Departments of Pathology   (Italy)

^b Departments of Surgery   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ALLELE; ANEUPLOIDY; ARTICLE; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 20Q; CHROMOSOME 6Q; CHROMOSOME LOSS; CORRELATION FUNCTION; DNA DETERMINATION; ENDOCRINE TUMOR; FEMALE; GENE DELETION; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS TUMOR; PLOIDY; PRIORITY JOURNAL;

ADENOMA, ISLET CELL; ADULT; AGED; ANALYSIS OF VARIANCE; CHROMOSOME DELETION; DNA, NEOPLASM; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MULTIVARIATE ANALYSIS; PANCREATIC NEOPLASMS; PLOIDIES; SURVIVAL ANALYSIS;

EID: 0035138085     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Functioning insulinoma-incidence, recurrence and long-term survival of patients: A 60 year study
2. Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors
3. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy
4. Islet cell carcinoma of the pancreas. A study of 98 patients
5. Revised classification of neuroendocrine tumours of the lung, pancreas and gut
6. Management of non-functioning neuroendocrine tumours of the pancreas
7. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas
8. Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors
9. Tumor suppressive pathways in pancreatic carcinoma
10. K-ras and p53 gene mutations in pancreatic cancer: Ductal and nonductal tumors progress through different genetic lesions
11. Pancreatic endocrine tumours: Evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p
12. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: An analysis of p16/MTS1 tumor suppressor gene inactivation
13. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors
14. Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors
15. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors
16. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications
17. Deletion of chromosome I predicts prognosis in pancreatic endocrine tumors
18. Allelotype of pancreatic adenocarcinoma using xenograft enrichment
19. Molecular characterization of pancreatic serous microcystic adenomas: Evidence for a tumor suppressor gene on chromosome 10q
20. Allelotype of pancreatic acinar cell carcinoma
21. Histological typing of endocrine tumors
22. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables
23. Chromosome 7q allelic losses in pancreatic carcinoma
24. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry
25. Regression models and life-tables
26. Prognostic criteria in nonfunctioning pancreatic endocrine tumours
27. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization
28. 6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas
29. Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1
30. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas
31. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23
32. Pancreatic tumors: Molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
33. Nuclear DNA content in 27 pancreatic endocrine tumours: Correlation with malignancy, survival and expression of glycoprotein hormone α chain
34. Malignant potential of aneuploid pancreatic endocrine tumours
35. Genetic instabilities in human cancers